XAMIOL 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g gel bottle Australia - English - Department of Health (Therapeutic Goods Administration)

xamiol 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g gel bottle

leo pharma pty ltd - calcipotriol, quantity: 50 microgram/g; betamethasone dipropionate (equivalent: betamethasone, qty 500 microgram/g) - gel - excipient ingredients: nitrogen; butylated hydroxytoluene; liquid paraffin; dl-alpha-tocopherol; polyoxypropylene-11 stearyl ether; hydrogenated castor oil - xamiol 50/500 gel is indicated for the topical treatment of scalp psoriasis

Enstilar 50 micrograms/0.5mg/g cutaneous foam. Malta - English - Medicines Authority

enstilar 50 micrograms/0.5mg/g cutaneous foam.

leo pharma a/s industriparken 55, 2750-dk ballerup, denmark - calcipotriol monohydrate, betamethasone dipropionate - cutaneous foam - calcipotriol monohydrate 50 µg/g betamethasone dipropionate 0.5 mg/g - antipsoriatics

Enstilar® (Calcipotriol 50 mcgg + Bethamethasone Dipropionate 0.5 mgg) Cutaneous Foam Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

enstilarâ® (calcipotriol 50 mcgg + bethamethasone dipropionate 0.5 mgg) cutaneous foam

dksh malaysia sdn. bhd. - betamethasone dipropionate; calcipotriol monohydrate -

Wynzora 50 micrograms/g + 0.5 mg/g cream Ireland - English - HPRA (Health Products Regulatory Authority)

wynzora 50 micrograms/g + 0.5 mg/g cream

almirall, s.a. - calcipotriol; betamethasone - cream - 50 micrograms/g + 0.5 milligram(s)/gram - calcipotriol, combinations

GLENBEX Calcipotriol (as monohydrate) 50 microgram/g and Betamethasone (as dipropionate) 500 microgram/g Foam Aerosol Can Australia - English - Department of Health (Therapeutic Goods Administration)

glenbex calcipotriol (as monohydrate) 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g foam aerosol can

freyr australia pty ltd - betamethasone dipropionate, quantity: 643 microgram/g (equivalent: betamethasone, qty 500 microgram/g); calcipotriol monohydrate, quantity: 52.2 microgram/g - foam - excipient ingredients: propane; polyoxypropylene-11 stearyl ether; isobutane; d-alpha-tocopherol; isopropyl alcohol; butane; white soft paraffin; liquid paraffin - topical treatment of psoriasis vulgaris in adults.

Daivonex Scalp Solution New Zealand - English - Medsafe (Medicines Safety Authority)

daivonex scalp solution

leo pharma limited - calcipotriol 50 µg/ml - topical solution - 50 mcg/g - active: calcipotriol 50 µg/ml excipient: hyprolose isopropyl alcohol levomenthol propylene glycol purified water sodium citrate dihydrate

Daivonex New Zealand - English - Medsafe (Medicines Safety Authority)

daivonex

leo pharma limited - calcipotriol 50 µg/g - topical cream - 50 mcg/g - active: calcipotriol 50 µg/g excipient: cetomacrogol 1000 cetostearyl alcohol dibasic sodium phosphate dihydrate disodium edetate dihydrate glycerol liquid paraffin n-(3-chloroallyl)hexaminium chloride purified water white soft paraffin

Dovobet 50 microgram/g + 0.5 mg/g gel Ireland - English - HPRA (Health Products Regulatory Authority)

dovobet 50 microgram/g + 0.5 mg/g gel

pco manufacturing ltd. - calcipotriol; betamethasone - gel - 50 mcg/g + - other antipsoriatics for topical use; calcipotriol, combinations

Dovobet 50 microgram/g + 0.5 mg/g gel Ireland - English - HPRA (Health Products Regulatory Authority)

dovobet 50 microgram/g + 0.5 mg/g gel

leo pharma a/s - calcipotriol; betamethasone - gel - 50 mcg/g + 0.5 milligram(s)/gram - other antipsoriatics for topical use; calcipotriol, combinations

Dovobet® 50 microgram/g + 0.5 mg/g ointment Ireland - English - HPRA (Health Products Regulatory Authority)

dovobet® 50 microgram/g + 0.5 mg/g ointment

leo pharma a/s - calcipotriol; betamethasone - ointment - 50 mcg/g +0.5 milligram(s)/gram - other antipsoriatics for topical use; calcipotriol, combinations